Tafamidis meglumine

Tafamidis meglumine is an organoammonium salt obtained by combining tafamidis with one molar equivalent of 1-deoxy-1-(methylamino)-D-glucitol. Used for the amelioration of transthyretin-related hereditary amyloidosis. Among its listed roles, it functions as a central nervous system drug. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Vyndaqel, 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-(3, 5-dichlorophenyl)-1 and 3-benzoxazole-6-carboxylate. Its PubChem CID is 24970412.

CAS No 951395-08-7
Molecular Formula C21H24Cl2N2O8
Molecular Weight 503.3 g/mol
Synonyms 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol

Frequently Asked Questions